S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Perceptive Advisors/Q3 2023

Perceptive Advisors

Periodo: Q3 2023 Β· Depositato: 2023-11-14
Vedi su SEC EDGAR β†—
AUM
$3.00B
Valore totale del portafoglio
Posizioni
97
Titoli dichiarati
Prima Posizione
FOLD
11.2% $336.8M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-11-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
FOLDAMICUS THERAPEUTICS INC$336.8M11.23%β€”β€”
11.2%
CERECEREVEL THERAPEUTICS HLDNG I$220.2M7.35%β€”β€”
7.3%
IMVTIMMUNOVANT INC$146.4M4.88%$34.64$38.79+12.0%
4.9%
ACLXARCELLX INC$142.3M4.75%$34.66β€”
4.8%
NUVLNUVALENT INC$113.2M3.78%$45.81$123.73+170.1%
3.8%
SLNOSOLENO THERAPEUTICS INC$90.7M3.03%$26.48β€”
3.0%
LIANYLIANBIO$85.8M2.86%$0.00$0.12
2.9%
AKROAKERO THERAPEUTICS INC$81.9M2.73%β€”β€”
2.7%
INBXINHIBRX INC$78.1M2.61%β€”$97.58
2.6%
ALDXALDEYRA THERAPEUTICS INC$75.8M2.53%$6.06$2.27-62.5%
2.5%
ARGXARGENX SE$74.0M2.47%$487.32$939.68+92.8%
2.5%
PCVXVAXCYTE INC$68.5M2.28%$49.04$58.39+19.1%
2.3%
VRNAVERONA PHARMA PLC$65.3M2.18%β€”β€”
2.2%
CBAYCYMABAY THERAPEUTICS INC$60.3M2.01%β€”β€”
2.0%
MGTXMEIRAGTX HLDGS PLC$55.6M1.86%$4.65$13.92+199.3%
1.9%
IOVAIOVANCE BIOTHERAPEUTICS INC$54.4M1.82%$4.43$4.31-2.7%
1.8%
LYRAXXXXLYRA THERAPEUTICS INC$49.9M1.66%β€”β€”
1.7%
AMLXAMYLYX PHARMACEUTICALS INC$49.2M1.64%$18.12$18.27+0.8%
1.6%
BBIOBRIDGEBIO PHARMA$46.1M1.54%$25.41$77.19+203.8%
1.5%
MDTMEDTRONIC PLC$46.0M1.53%$71.07$83.19+17.1%
1.5%
ROIVROIVANT SCIENCES LTD$44.6M1.49%$10.52$35.13+233.9%
1.5%
IRONDISC MEDICINE INC$42.1M1.40%$45.65$76.26+67.0%
1.4%
IMTXIMMATICS N.V$40.4M1.35%$10.79$9.95-7.8%
1.4%
APGEAPOGEE THERAPEUTICS INC$38.9M1.30%$20.40$132.91+551.5%
1.3%
CRNXCRINETICS PHARMACEUTICALS IN$37.6M1.25%$27.14$42.23+55.6%
1.3%
RVMDREVOLUTION MEDICINES INC$36.6M1.22%$26.17$189.24+623.1%
1.2%
SWTXSPRINGWORKS THERAPEUTICS INC$35.1M1.17%β€”β€”
1.2%
AXSMAXSOME THERAPEUTICS INC$33.7M1.12%$66.85$244.31+265.5%
1.1%
HRMYHARMONY BIOSCIENCES HLDGS IN$32.6M1.09%$32.44$37.26+14.9%
1.1%
RAPTRAPT THERAPEUTICS INC$31.9M1.06%β€”β€”
1.1%

AttivitΓ  Trimestre su Trimestre

Q3 2023 vs. Q2 2023

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
APGEAPOGEE THERAPEUTICS INC$38.9M+551.5%
RVMDREVOLUTION MEDICINES INC$36.6M+623.1%
TNGXTANGO THERAPEUTICS INC$27.2M
RYZBRAYZEBIO INC$17.3M
EOLSEVOLUS INC$13.6M
RYTMRHYTHM PHARMACEUTICALS INC$8.7M
NVAXPUTNOVAVAX INC$3.8M
EYPTPUTEYEPOINT PHARMACEUTICALS INC$2.5M

Posizioni Chiuse (8)

TickerEmittenteNozionale
RETAREATA PHARMACEUTICALS INC$68.3M
VIRVIR BIOTECHNOLOGY INC$48.0M
ILMNILLUMINA INC$27.2M
MRTXMIRATI THERAPEUTICS INC$26.0M
BMRNBIOMARIN PHARMACEUTICAL INC$22.8M
ITCIINTRA-CELLULAR THERAPIES INC$15.6M
ISEEIVERIC BIO INC$6.6M
QTRXQUANTERIX CORP$2.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VERUXXXXVERU INC$0.7M+1112.6%
VRNAVERONA PHARMA PLC$64.6M+701.4%
TVTXTRAVERE THERAPEUTICS INC$2.2M+340.8%
BHVNBIOHAVEN LTD$11.9M+134.3%
SRPTCALLSAREPTA THERAPEUTICS INC$12.9M+125.4%
ARGXARGENX SE$47.1M+118.3%+92.8%
AXSMAXSOME THERAPEUTICS INC$14.2M+77.4%+265.5%
PNTPUTPOINT BIOPHARMA GLOBAL INC$2.0M+60.0%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CYPHLEAP THERAPEUTICS INC$-1.8M-92.3%
APLSPUTAPELLIS PHARMACEUTICALS INC$-73.9M-87.7%
MDGLMADRIGAL PHARMACEUTICALS INC$-51.8M-58.9%
AKROCALLAKERO THERAPEUTICS INC$-85.2M-58.8%
XENEXENON PHARMACEUTICALS INC$-26.0M-49.5%
NBTXNANOBIOTIX$-0.5M-47.6%
NTRANATERA INC$-10.1M-46.2%
AMLXAMYLYX PHARMACEUTICALS INC$-55.9M-44.8%+0.8%
← Torna agli Hedge Fund